Skip to main content
Figure 4 | Molecular Cancer

Figure 4

From: Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity

Figure 4

KB9520 pre-treatment synergizes with cisplatin. A) Effect of adding of cisplatin (100 μM) 2, 4, 8 or 12 hours after start of KB9520 (10 nM) treatment on REN cell viability. B) Effect of adding KB9520 (10 nM) 2, 4, 8 or 12 hours after start of cisplatin treatment (100 μM) on REN cell viability. Each graph is representative of three independent experiments. Each point represents mean ± s.d. *p ≤ 0.05.

Back to article page

Molecular Cancer

ISSN: 1476-4598